Two‐year follow‐up comparing Rezūm therapy versus bipolar transurethral resection of the prostate for treating benign prostatic hyperplasia. A prospective randomized study
International Journal of Urology · 2024
DOI: 10.1111/iju.15410 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift International Journal of Urology, 2024. Verfasst von Mohamed Samir und 3 weiteren Autor:innen. Beteiligte Einrichtung: Ain Shams University, Cairo, Egypt. Hauptthemen laut MEDLINE: Prostatic Hyperplasia, Transurethral Resection of Prostate, Quality of Life, Bacterial Toxins. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 21 Literaturangaben.
Abstract (Originalsprache)
Objective
Comparison of the efficacy and safety of Rezūm therapy and bipolar transurethral resection of prostate (B‐TURP) for the management of benign prostatic hyperplasia (BPH) of 50–120 g size.
Methods
One hundred patients with BPH who met the inclusion criteria were included and split into two equal groups to undergo Rezūm therapy or B‐TURP. The two groups were compared for efficacy using international prostate symptom score (IPSS), quality of life (QoL), maximum urinary flow rate (Q max ), operative time, catheter time, hospital stay, post‐void residual urine (PVR), prostate‐specific antigen (PSA), and residual prostate size and safety using the incidence of complications.
Results
Rezūm significantly ameliorated IPSS from the baseline score by 55.3%, QoL by 50%, Q max by 62.5%, International Index of Erectile Function (IIEF) by 7.1%, PVR by 50%, residual prostate size by 28.1% and PSA by 42% at 2 years. Meanwhile, the improvement in B‐TURP was significantly higher than Rezūm group, Rezūm therapy had a significantly shorter duration of operative time and hospital stay. Also, it had fewer complications in comparison with B‐TURP.
Conclusions
Rezūm is a minimally invasive procedure that provides significantly improved symptomatic relief of BPH and quality of life with preservation of erectile and ejaculatory functions. However, it is not as effective as B‐TURP.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Ain Shams University, Cairo, Egypt.
- Military Medical Academy, Heliopolis, Egypt.
ORCID-Profile: Mohamed Samir
Zitieren
APA
Samir, M., Elaal, A. A. A., Gad, K. A. S., & Basyony, M. W. (2024). Two‐year follow‐up comparing Rezūm therapy versus bipolar transurethral resection of the prostate for treating benign prostatic hyperplasia. A prospective randomized study. International Journal of Urology. https://doi.org/10.1111/iju.15410
Vancouver
Samir M, Elaal AAA, Gad KAS, Basyony MW. Two‐year follow‐up comparing Rezūm therapy versus bipolar transurethral resection of the prostate for treating benign prostatic hyperplasia. A prospective randomized study. International Journal of Urology. 2024. doi:10.1111/iju.15410
BibTeX
@article{Samir2024,
author = {Samir, Mohamed and Elaal, Abd Allah Abd and Gad, Khaled Abdel Sattar and Basyony, Mohamed Wagieh},
title = {Two‐year follow‐up comparing Rezūm therapy versus bipolar transurethral resection of the prostate for treating benign prostatic hyperplasia. A prospective randomized study},
journal = {International Journal of Urology},
year = {2024},
doi = {10.1111/iju.15410}
}
EUVIMED